Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/43189
Type
ArticleCopyright
Open access
Sustainable Development Goals
03 Saúde e Bem-EstarCollections
- IOC - Artigos de Periódicos [12973]
Metadata
Show full item record
MYCOBACTERIUM BOVIS BCG MOREAU IS NATURALLY DEFICIENT IN HOMOLOGOUS RECOMBINATION
Mycobacterium bovis BCG Moreau
Vacina contra tuberculose
Mycobacterium bovis BCG Moreau
Recombineering
Tuberculosis vaccine
Author
Affilliation
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genômica Funcional e Bioinformática. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genômica Funcional e Bioinformática. Rio de Janeiro, RJ, Brasil.
Centre National de La Recherche Scientifique. Institut de Pharmacologie et de Biologie Structurale. Toulouse, France.
Centre National de La Recherche Scientifique. Institut de Pharmacologie et de Biologie Structurale. Toulouse, France.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genômica Funcional e Bioinformática. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genômica Funcional e Bioinformática. Rio de Janeiro, RJ, Brasil.
Centre National de La Recherche Scientifique. Institut de Pharmacologie et de Biologie Structurale. Toulouse, France.
Centre National de La Recherche Scientifique. Institut de Pharmacologie et de Biologie Structurale. Toulouse, France.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genômica Funcional e Bioinformática. Rio de Janeiro, RJ, Brasil.
Abstract
The ability to perform genetic manipulation of mycobacteria is important for characterization of gene function. Homologous recombination-based protocols are frequently used for reverse genetics studies with mycobacteria. It is known that Mycobacterium bovis BCG Russia, closely related to M. bovis BCG Moreau, is a natural recA deficient strain and is non-permissive to homologous recombination assays. In this work we show that M. bovis BCG Moreau is also deficient in homologous recombination, shown by a specialized transduction assay, but this phenotype can be reverted by complementation with heterologous recombinases, using a recombineering protocol. Sequence analysis of the genes known to be involved in homologous recombination annotated in the genome of BCG Moreau detected no differences compared to the genome of BCG Pasteur. Further studies are needed in order to determine the exact mechanism underlying this deficiency in BCG Moreau.
Keywords in Portuguese
Recombinação homólogaMycobacterium bovis BCG Moreau
Vacina contra tuberculose
Keywords
Homologous recombinationMycobacterium bovis BCG Moreau
Recombineering
Tuberculosis vaccine
Share